314 related articles for article (PubMed ID: 11673801)
1. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.
Rybakowski JK; Borkowska A; Czerski PM; Hauser J
Mol Psychiatry; 2001 Nov; 6(6):718-24. PubMed ID: 11673801
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
3. [Study of association between the ser-9-gly polymorphism of the D3 dopaminergic receptor and schizophrenia].
Cordeiro Q; Junqueira R; Vallada H
Arq Neuropsiquiatr; 2001 Jun; 59(2-A):219-22. PubMed ID: 11400029
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
5. Association study between schizophrenia and dopamine D3 receptor gene polymorphism.
Tanaka T; Igarashi S; Onodera O; Tanaka H; Takahashi M; Maeda M; Kameda K; Tsuji S; Ihda S
Am J Med Genet; 1996 Jul; 67(4):366-8. PubMed ID: 8837704
[TBL] [Abstract][Full Text] [Related]
6. Association between schizophrenia and DRD3 or HTR2 receptor gene variants.
Baritaki S; Rizos E; Zafiropoulos A; Soufla G; Katsafouros K; Gourvas V; Spandidos DA
Eur J Hum Genet; 2004 Jul; 12(7):535-41. PubMed ID: 15083167
[TBL] [Abstract][Full Text] [Related]
7. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.
Woo SI; Kim JW; Rha E; Han SH; Hahn KH; Park CS; Sohn JW
Psychiatry Clin Neurosci; 2002 Aug; 56(4):469-74. PubMed ID: 12109967
[TBL] [Abstract][Full Text] [Related]
8. COMT val(158)met genotype and smooth pursuit eye movements in schizophrenia.
Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
Psychiatry Res; 2009 Sep; 169(2):173-5. PubMed ID: 19647329
[TBL] [Abstract][Full Text] [Related]
9. Ser9Gly polymorphism in the dopamine D3 receptor gene is not associated with essential hypertension in the Japanese.
Soma M; Nakayama K; Rahmutula D; Uwabo J; Sato M; Kunimoto M; Aoi N; Kosuge K; Kanmatsuse K
Med Sci Monit; 2002 Jan; 8(1):CR1-4. PubMed ID: 11796958
[TBL] [Abstract][Full Text] [Related]
10. No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population.
Kremer I; Rietschel M; Dobrusin M; Mujaheed M; Murad I; Blanaru M; Bannoura I; Müller DJ; Schulze TG; Reshef A; Gathas S; Schwab S; Wildenauer D; Bachner-Melman R; Belmaker RH; Maier W; Ebstein RP
Am J Med Genet; 2000 Dec; 96(6):778-80. PubMed ID: 11121180
[TBL] [Abstract][Full Text] [Related]
11. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
[TBL] [Abstract][Full Text] [Related]
12. Trend for an association between schizophrenia and D3S1310, a marker in proximity to the dopamine D3 receptor gene.
Jönsson EG; Nimgaonkar VL; Zhang XR; Shaw SH; Burgert E; Crocq MA; Chakravarti A; Sedvall GC
Am J Med Genet; 1999 Aug; 88(4):352-7. PubMed ID: 10402502
[TBL] [Abstract][Full Text] [Related]
13. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ
Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179
[TBL] [Abstract][Full Text] [Related]
14. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
[TBL] [Abstract][Full Text] [Related]
15. Association study of dopamine D3 receptor gene and schizophrenia.
Kennedy JL; Billett EA; Macciardi FM; Verga M; Parsons TJ; Meltzer HY; Lieberman J; Buchanan JA
Am J Med Genet; 1995 Dec; 60(6):558-62. PubMed ID: 8825896
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between the effectiveness of atypical antipsychotics and dopamine D3 receptor polymorphism in schizophrenia].
Szekeres G; Juhász A; Kéri S; Rimanóczy A; Szendi I; Szabó Z; Janka Z
Ideggyogy Sz; 2002 Nov; 55(11-12):377-81. PubMed ID: 12632798
[TBL] [Abstract][Full Text] [Related]
17. Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting.
Kim B; Choi EY; Kim CY; Song K; Joo YH
Hum Psychopharmacol; 2008 Jan; 23(1):61-7. PubMed ID: 17924589
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Lerer B; Segman RH; Fangerau H; Daly AK; Basile VS; Cavallaro R; Aschauer HN; McCreadie RG; Ohlraun S; Ferrier N; Masellis M; Verga M; Scharfetter J; Rietschel M; Lovlie R; Levy UH; Meltzer HY; Kennedy JL; Steen VM; Macciardi F
Neuropsychopharmacology; 2002 Jul; 27(1):105-19. PubMed ID: 12062911
[TBL] [Abstract][Full Text] [Related]
19. Habit learning and the genetics of the dopamine D3 receptor: evidence from patients with schizophrenia and healthy controls.
Kéri S; Juhász A; Rimanóczy A; Szekeres G; Kelemen O; Cimmer C; Szendi I; Benedek G; Janka Z
Behav Neurosci; 2005 Jun; 119(3):687-93. PubMed ID: 15998189
[TBL] [Abstract][Full Text] [Related]
20. The study of cytosolic phospholipase A2 gene polymorphism in schizophrenia using eye movement disturbances as an endophenotypic marker.
Rybakowski JK; Borkowska A; Czerski PM; Dmitrzak-Weglarz M; Hauser J
Neuropsychobiology; 2003; 47(3):115-9. PubMed ID: 12759552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
